ARKG 02/20/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
102/20/2024CRISPR THERAPEUTICS AGCRSPH171821088.06%1,863,070 (0) (0%)$153,181,615.40
202/20/2024EXACT SCIENCES CORPEXAS30063P1056.45%2,009,665 (-36,964) (-1.81%)$122,529,275.05
302/20/2024RECURSION PHARMACEUTICALS-ARXRX75629V1046.34%9,158,110 (0) (0%)$120,429,146.50
402/20/2024TWIST BIOSCIENCE CORPTWST90184D1006.07%2,819,571 (0) (0%)$115,292,258.19
502/20/2024SCHRODINGER INCSDGR80810D1034.63%2,704,562 (0) (0%)$87,898,265.00
602/20/2024TELADOC HEALTH INCTDOC87918A1054.36%3,939,223 (0) (0%)$82,841,859.69
702/20/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1004.06%52,471,364 (0) (0%)$77,132,905.08
802/20/2024BEAM THERAPEUTICS INCBEAM07373V1054.00%2,308,405 (0) (0%)$75,946,524.50
902/20/2024ACCOLADE INCACCD00437E1023.92%6,026,616 (0) (0%)$74,488,973.76
1002/20/202410X GENOMICS INC-CLASS ATXG88025U1093.73%1,460,736 (1,977) (0.14%)$70,772,659.20
1102/20/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1083.64%12,049,387 (119,824) (1%)$69,163,481.38
1202/20/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.53%1,815,020 (0) (0%)$67,010,538.40
1302/20/2024IONIS PHARMACEUTICALS INCIONS4622221003.51%1,502,991 (-15,824) (-1.04%)$66,777,890.13
1402/20/2024INTELLIA THERAPEUTICS INCNTLA45826J1053.34%2,288,501 (0) (0%)$63,483,017.74
1502/20/2024CAREDX INCCDNA14167L1032.70%6,298,460 (0) (0%)$51,206,479.80
1602/20/2024VERACYTE INCVCYT92337F1072.64%2,026,404 (0) (0%)$50,133,234.96
1702/20/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.34%105,144 (0) (0%)$44,391,796.80
1802/20/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.32%200,890 (0) (0%)$44,065,221.50
1902/20/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.30%11,348,878 (0) (0%)$43,693,180.30
2002/20/2024VERVE THERAPEUTICS INCVERV92539P1012.10%3,045,048 (0) (0%)$39,859,678.32
2102/20/2024STANDARD BIOTOOLS INCLAB34385P1081.89%14,004,555 (0) (0%)$35,991,706.35
2202/20/2024UIPATH INC – CLASS APATH90364P1051.71%1,298,082 (0) (0%)$32,400,126.72
2302/20/2024MODERNA INCMRNA60770K1071.69%363,384 (0) (0%)$32,112,244.08
2402/20/2024NURIX THERAPEUTICS INCNRIX67080M1031.47%2,829,352 (0) (0%)$27,925,704.24
2502/20/2024PRIME MEDICINE INCPRME74168J1011.45%3,266,948 (0) (0%)$27,638,380.08
2602/20/2024908 DEVICES INCMASS65443P1021.45%3,804,616 (0) (0%)$27,507,373.68
2702/20/2024INCYTE CORPINCY45337C1021.44%471,161 (0) (0%)$27,308,491.56
2802/20/2024COMPASS PATHWAYS PLCCMPS20451W1011.28%2,321,104 (0) (0%)$24,394,803.04
2902/20/2024QUANTUM-SI INCQSI74765K1051.23%13,713,750 (0) (0%)$23,313,375.00
3002/20/2024REGENERON PHARMACEUTICALSREGN75886F1071.12%22,397 (0) (0%)$21,233,475.85
3102/20/2024REPARE THERAPEUTICS INCRPTX7602731021.01%2,904,442 (0) (0%)$19,256,450.46
3202/20/2024NVIDIA CORPNVDA67066G1040.91%23,882 (0) (0%)$17,341,436.66
3302/20/2024CERUS CORPCERS1570851010.77%6,195,820 (0) (0%)$14,622,135.20
3402/20/2024BUTTERFLY NETWORK INCBFLY1241551020.68%12,131,064 (0) (0%)$12,858,927.84
3502/20/2024AMGEN INCAMGN0311621000.66%44,150 (0) (0%)$12,525,355.00
3602/20/2024GUARDANT HEALTH INCGH40131M1090.46%387,836 (0) (0%)$8,695,283.12
3702/20/2024PERSONALIS INCPSNL71535D1060.40%5,621,395 (0) (0%)$7,645,097.20
3802/20/2024PFIZER INCPFE7170811030.18%123,488 (0) (0%)$3,410,738.56
3902/20/2024ABSCI CORPABSI00091E1090.13%464,191 (0) (0%)$2,474,138.03
4002/20/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,734,826 (0) (0%)$713,360.45
4102/20/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$100,115.28
4202/20/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.01%162,681 (-1,059,326) (-86.69%)$162,681.05
4302/20/2024INVITAE CORPNVTAQ46185L1030.00%3,920 (0) (0%)$76.44
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment